ScoreWhy is Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 5.98% and Operating profit at -4.37% over the last 5 years
2
The company has declared negative results in Mar'2025 after 2 consecutive positive quarters
- NET PROFIT(HY) At CNY 326.44 MM has Grown at -22.55%
- INTEREST COVERAGE RATIO(Q) Lowest at 860.02
- INTEREST(Q) Highest at CNY 18.09 MM
3
With ROE of 10.58%, it has a fair valuation with a 2.58 Price to Book Value
- Over the past year, while the stock has generated a return of -24.16%, its profits have risen by 274.8% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 0.9
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -24.16% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
-33.21%
-0.84
30.33%
China Shanghai Composite
21.43%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.61%
EBIT Growth (5y)
-6.41%
EBIT to Interest (avg)
9.83
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.44
Tax Ratio
17.16%
Dividend Payout Ratio
27.78%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.32%
ROE (avg)
13.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
1.86
EV to EBIT
16.92
EV to EBITDA
13.48
EV to Capital Employed
1.96
EV to Sales
3.04
PEG Ratio
NA
Dividend Yield
1.24%
ROCE (Latest)
11.60%
ROE (Latest)
7.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at -10.14 %
INVENTORY TURNOVER RATIO(HY)
Highest at 0.79 times
RAW MATERIAL COST(Y)
Fallen by -2.62% (YoY
CASH AND EQV(HY)
Highest at CNY 6,098.27 MM
-20What is not working for the Company
INTEREST(Q)
At CNY 16.38 MM has Grown at 31.13%
INTEREST COVERAGE RATIO(Q)
Lowest at 592.2
OPERATING PROFIT(Q)
Lowest at CNY 97 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 10.44 %
PRE-TAX PROFIT(Q)
Lowest at CNY 68.78 MM
NET PROFIT(Q)
Lowest at CNY 62.66 MM
EPS(Q)
Lowest at CNY 0.05
Here's what is working for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Debt-Equity Ratio
Lowest at -10.14 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 0.79 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Cash and Eqv
Highest at CNY 6,098.27 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -2.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 68.78 MM has Fallen at -58.01%
over average net sales of the previous four periods of CNY 163.82 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Interest
At CNY 16.38 MM has Grown at 31.13%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 592.2
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Net Profit
At CNY 62.66 MM has Fallen at -54.32%
over average net sales of the previous four periods of CNY 137.16 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Profit
Lowest at CNY 97 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 10.44 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 68.78 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 62.66 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.05
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
